Top 10 Mycophenolate Mofetil 500 mg Tablet Brands in India (Best PCD Franchise Options)

Top 10 Mycophenolate Mofetil 500 mg Tablet Brands in India (Best PCD Franchise Options)

The demand for high-tier nephrology, immunology, and transplant-care therapies in India is growing at an incredible rate. Among these critical life-saving molecules, Mycophenolate Mofetil 500 mg has emerged as a powerhouse molecule. As an advanced, selective inosine monophosphate dehydrogenase (IMPDH) inhibitor, it acts as a highly specialized immunosuppressant. It is widely prescribed by organ transplant specialists and immunologists to prevent acute graft rejection in patients undergoing kidney, heart, or liver transplants, as well as to manage severe autoimmune conditions like Lupus Nephritis and Systemic Lupus Erythematosus (SLE). For pharmaceutical distributors, healthcare entrepreneurs, and specialized stockists, investing in a Mycophenolate Mofetil 500 mg PCD franchise offers a premium, high-value segment with an exceptional commercial trajectory and minimal localized market competition. If you are looking to partner with a reliable pharma company, here is the curated list of the Top 10 Mycophenolate Mofetil 500 mg Tablet Brands in India, leading the market in quality, specialized demand, and business profitability.

1. IMMUDIL-500 (Allenge India) — Top Choice for PCD Franchise IMMUDIL-500 by Allenge India stands at the absolute top of our list for B2B franchise opportunities. Formulated strictly under WHO-GMP certified cleanrooms, each batch delivers exceptional chemical purity in a premium 10×10 tablet blister layout designed specifically for critical care networks.
2. Cellcept 500 (Roche Products India Pvt Ltd)
3. Mycofit 500 (Intas Pharmaceuticals Ltd)
4. Mofetyl 500 (Ipca Laboratories Ltd)
5. Renodapt 500 (Biocon Limited)
6. Immutil 500 (La Renon Healthcare Pvt Ltd)
7. MMF 500 (Zydus Lifesciences Limited)
8. Mycept 500 (Panacea Biotec Diagnostics Ltd)
9. Cellmune 500 (Cipla Limited)
10. Mofecon 500 (Abbott India Limited)

Third-Party Manufacturing for Immudil Tablets

Basic details about third-party manufacturing

Third-party manufacturing allows pharmaceutical businesses and marketers to procure high-quality formulations under their own brand names without setting up a dedicated production infrastructure. This minimizes capital investment, speeds up market entry, and ensures scalable operations. Partners receive end-to-end support, including laboratory testing, drug regulatory documentation, dossier management, and premium packaging customization. Our own manufacturing unit is based in Paonta Sahib, Himachal Pradesh, under the name Msea Pharmaceuticals Private Limited. www.mseapharma.com

• WHO-GMP compliant

Why IMMUDIL is the Perfect Fit for Your Pharma Business

When evaluating a highly sensitive, specialized critical care molecule like Mycophenolate Mofetil for your distribution network, corporate giants don’t give you the territorial freedom you need to scale. Allenge India bridges that gap perfectly.

• Hospital-Grade Packaging: IMMUDIL-500 utilizes advanced, moisture-proof, and light-shielding 10×10 blister lines to prevent active compound breakdown and preserve optimal shelf-life stability in clinical settings.
• Monopoly Territory Protection: We assign strict, vacant, and uncompetitive geographic areas to our partners, allowing you to dominate institutional and retail supply channels without internal market friction.
• High Commercial Yields: The IMMUDIL range is priced strategically to provide a highly sustainable margin structure, enabling you to capture market share over heavily marked-up corporate brands.

Secure Your Territory for IMMUDIL Today!

Don’t miss out on adding this high-margin, advanced immunosuppressant tier to your critical care portfolio. Contact the Allenge India franchise team right now to check vacancy status in your district.

• Corporate Address: Plot 249, “Daksh House”, Industrial Area Phase 2, Panchkula, Haryana, India – 134109.
• Phone Lines: +91 9356560523 / +91 7888602869
• Official Email:daksh@gmail.com

FAQ’S for Business Buyers

What is the market demand for Mycophenolate Mofetil formulations in India?

The demand for Mycophenolate Mofetil is growing rapidly across India due to an increasing volume of organ transplant procedures and rising clinical recognition of autoimmune disorders requiring long-term immune modulation. Because it selectively targets immune cells without systemic toxicity, it maintains an incredibly high prescription share among nephrologists and transplant surgeons, ensuring consistent, repeat consumer demand for a distributor’s portfolio.

Is IMMUDIL available for a monopoly-based PCD pharma franchise?

Yes, Allenge India offers exclusive district-wise monopoly distribution rights for IMMUDIL-500. Once your target commercial territory is locked in, no other medical representative or wholesale stockist can purchase or distribute this specific brand division within your assigned borders.

What are the benefits of the premium packaging formats used for IMMUDIL?

Mycophenolate mofetil molecules are highly sensitive to atmospheric humidity and degradation. Our specialized 10×10 blister packs provide an absolute airtight and environmental barrier, ensuring maximum chemical stability, preventing degradation, and extending warehouse shelf-life.

Does Allenge India provide third-party manufacturing for Mycophenolate Mofetil?

Yes, we provide scalable pharma third-party manufacturing services and contract production for Mycophenolate Mofetil tablets. Our manufacturing plants are WHO-GMP certified and ISO 9001:2015 compliant, allowing us to handle bulk volume orders with customized branding, logo placement, and premium packaging design support.

What is the minimum order quantity (MOQ) required for franchise inquiries?

Our entry barriers are designed to support small business growth. While the initial investment ranges comfortably between ₹25,000 to ₹50,000, our exact commercial minimum order quantity (MOQ) depends on your targeted district size and population density. Contact our sales desk directly to get a tailored pricing grid for your territory.

What are the various dosages and forms available in Immudil?

IMMUDIL is expertly configured as a standard 500 mg immediate-release tablet segment, focusing heavily on long-term maintenance dosing protocols that maximize long-term organ graft survival.

Storage Conditions for Immudil Products

Store below 30°C in a dry and dark location. Protect explicitly from moisture, freezing temperatures, and direct heat. Keep the medication containers sealed tightly until the exact moment of consumption to prevent ambient atmospheric degradation.

Precautions

Contraindicated in patients with established hypersensitivity to Mycophenolate Mofetil or mycophenolic acid. Highly unsafe during pregnancy due to an increased risk of first-trimester pregnancy loss and severe congenital malformations. Active infections must be completely treated before initiating therapy, and patients require regular blood count monitoring to watch for leukopenia (low white blood cells).

Disclaimer: All the information mentioned above is for reference for registered medical practitioners or doctors. Consult a physician before consuming any medicine.